415 related articles for article (PubMed ID: 28624178)
1. Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.
Moris D; Tsilimigras DI; Ntanasis-Stathopoulos I; Beal EW; Felekouras E; Vernadakis S; Fung JJ; Pawlik TM
Surgery; 2017 Sep; 162(3):525-536. PubMed ID: 28624178
[TBL] [Abstract][Full Text] [Related]
2. Liver Transplant for Metastatic Neuroendocrine Tumors: A Single-Center Experience in Hungary.
Korda D; Doros A; Piros L; Gerlei Z; Haboub-Sandil A; Mándli T; Fazakas J; Deák ÁP; Máthé Z
Transplant Proc; 2019 May; 51(4):1251-1253. PubMed ID: 31101208
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study.
Le Treut YP; Grégoire E; Klempnauer J; Belghiti J; Jouve E; Lerut J; Castaing D; Soubrane O; Boillot O; Mantion G; Homayounfar K; Bustamante M; Azoulay D; Wolf P; Krawczyk M; Pascher A; Suc B; Chiche L; de Urbina JO; Mejzlik V; Pascual M; Lodge JP; Gruttadauria S; Paye F; Pruvot FR; Thorban S; Foss A; Adam R;
Ann Surg; 2013 May; 257(5):807-15. PubMed ID: 23532105
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for unresectable neuroendocrine tumor liver metastases.
Rossi RE; Burroughs AK; Caplin ME
Ann Surg Oncol; 2014 Jul; 21(7):2398-405. PubMed ID: 24562931
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.
van Vilsteren FG; Baskin-Bey ES; Nagorney DM; Sanderson SO; Kremers WK; Rosen CB; Gores GJ; Hobday TJ
Liver Transpl; 2006 Mar; 12(3):448-56. PubMed ID: 16498656
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for neuroendocrine tumour liver metastases.
Fan ST; Le Treut YP; Mazzaferro V; Burroughs AK; Olausson M; Breitenstein S; Frilling A
HPB (Oxford); 2015 Jan; 17(1):23-8. PubMed ID: 24992381
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for metastatic neuroendocrine tumors: Outcomes and prognostic variables.
Sher LS; Levi DM; Wecsler JS; Lo M; Petrovic LM; Groshen S; Ji L; Uso TD; Tector AJ; Hamilton AS; Marsh JW; Schwartz ME
J Surg Oncol; 2015 Aug; 112(2):125-32. PubMed ID: 26171686
[TBL] [Abstract][Full Text] [Related]
8. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
[TBL] [Abstract][Full Text] [Related]
9. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.
Rosenau J; Bahr MJ; von Wasielewski R; Mengel M; Schmidt HH; Nashan B; Lang H; Klempnauer J; Manns MP; Boeker KH
Transplantation; 2002 Feb; 73(3):386-94. PubMed ID: 11884935
[TBL] [Abstract][Full Text] [Related]
10. Metastases of pancreatic neuroendocrine tumor to the liver as extremely rare indication for liver transplantation in children. Case report and review of the literature.
Ismail H; Broniszczak D; Markiewicz-Kijewska M; Ciopiński M; Teisseyre J; Kluge P; Dembowska-Bagińska B; Kościesza A; Socha P; Kaliciński P
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):e33-7. PubMed ID: 26850362
[TBL] [Abstract][Full Text] [Related]
11. Outcomes following liver transplantation for metastatic neuroendocrine tumors.
Grąt M; Remiszewski P; Smoter P; Wronka KM; Grąt K; Lewandowski Z; Koperski L; Górnicka B; Pacho R; Zborowska H; Patkowski W; Krawczyk M
Transplant Proc; 2014 Oct; 46(8):2766-9. PubMed ID: 25380913
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for metastatic neuroendocrine tumors.
Lang H; Oldhafer KJ; Weimann A; Schlitt HJ; Scheumann GF; Flemming P; Ringe B; Pichlmayr R
Ann Surg; 1997 Apr; 225(4):347-54. PubMed ID: 9114792
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for the treatment of neuroendocrine liver metastases.
Vilchez V; Gedaly R
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):141-7. PubMed ID: 26971850
[TBL] [Abstract][Full Text] [Related]
14. [Liver trasplantation for the treatment of non-resectable metastases of neuroendocrine tumors: first report in Argentina].
Quiñonez E; Capitanich P; Anders M; Fernández JL; Serafini V; Viola L; Mastai R; McCormack L
Acta Gastroenterol Latinoam; 2011 Sep; 41(3):242-6. PubMed ID: 22233004
[TBL] [Abstract][Full Text] [Related]
15. Liver Transplantation for Neuroendocrine Tumors: What Have We Learned?
Lim C; Lahat E; Osseis M; Sotirov D; Salloum C; Azoulay D
Semin Liver Dis; 2018 Nov; 38(4):351-356. PubMed ID: 30357772
[TBL] [Abstract][Full Text] [Related]
16. Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis.
Tsilimigras DI; Ntanasis-Stathopoulos I; Kostakis ID; Moris D; Schizas D; Cloyd JM; Pawlik TM
J Gastrointest Surg; 2019 May; 23(5):1044-1054. PubMed ID: 30671800
[TBL] [Abstract][Full Text] [Related]
17. Resection versus transplantation for liver metastases from neuroendocrine tumors.
Coppa J; Pulvirenti A; Schiavo M; Romito R; Collini P; Di Bartolomeo M; Fabbri A; Regalia E; Mazzaferro V
Transplant Proc; 2001; 33(1-2):1537-9. PubMed ID: 11267413
[No Abstract] [Full Text] [Related]
18. The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: Pros and cons.
Sposito C; Droz Dit Busset M; Citterio D; Bongini M; Mazzaferro V
Rev Endocr Metab Disord; 2017 Dec; 18(4):473-483. PubMed ID: 29359266
[TBL] [Abstract][Full Text] [Related]
19. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.
Citterio D; Pusceddu S; Facciorusso A; Coppa J; Milione M; Buzzoni R; Bongini M; deBraud F; Mazzaferro V
Eur J Surg Oncol; 2017 Feb; 43(2):380-387. PubMed ID: 27956320
[TBL] [Abstract][Full Text] [Related]
20. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
